% CI #.#-#.# [003]

Related by string. % CI #.#-#.# [002] * : % ON HEAVY . % downside protection . -#.# % [002] . % RETURN SEEN / Cid . ci . CIS . CID : % CI #.#-#.# [006] . % CI #.#-#.# [007] . CI = . confidence interval CI / #.# [010] . #.# [027] . #.# [043] . #.# [031] : #.# ov #-# . Yard Freestyle =-#.# mg dL . #.# Promote sexually / #.# [009] . #.# [022] . #.# [039] : Rs #.# [005] . #.# Advocate promote . #.# ERA * *

Related by context. Frequent words. (Click for all words.) 81 % CI #.#-#.# [007] 77 confidence interval #.#-#.# 77 % CI #.#-#.# [006] 76 confidence interval CI 74 CI #.#-#.# [002] 74 P = .# 73 CI -#.# 72 CI = 70 median PFS 70 % CI #.#-#.# [002] 69 univariate analysis 68 biochemical recurrence 68 sd = 67 p = #.# [002] 67 n = 67 pg ml 67 placebo p = 67 pg mL 66 p = #.# [004] 66 plus dexamethasone 66 ng dL 66 serum concentrations 66 nmol L 66 statistically significant p = 65 virologic failure 65 patients evaluable 65 p = 65 Median survival 65 65 MetS 64 chlorambucil 64 annualized relapse 64 distant metastasis 64 leukopenia 64 plus methotrexate 64 mitoxantrone 64 virologic response 63 peginterferon alfa 2a 63 mg kg dose 63 μg kg 63 Secondary endpoints included 63 PREZISTA r 63 free survival PFS 63 multivariate analyzes 63 lymphopenia 63 RECIST criteria 63 mRCC 63 evaluable 63 achieved statistical significance 63 seroprotection 63 mg QD 62 Arch Intern Med 62 EBRT 62 vertebral fracture 62 FOLFIRI 62 ± SD 62 nondiabetic 62 PCa 62 univariate 62 liver transplant recipients 62 laboratory abnormalities 62 Secondary endpoints include 62 HbA1c levels 61 statistically significant p 61 mg d 61 HbA 1c 61 XELOX 61 HbA1C 61 ACR# response 61 LVEF 61 noncarriers 61 coinfected 61 hypokalemia 61 systolic BP 61 FOLFOX 61 complete cytogenetic 61 undetectable HCV RNA 61 placebo p 61 undetectable viral load 61 preoperatively 61 epithelial ovarian cancer 61 rheumatoid factor 61 cytogenetic response 61 distant metastases 61 androgen deprivation 61 IU mL 61 DAS# [002] 61 prevalences 61 serum PSA 61 plus gemcitabine 60 evaluable patients 60 ng ml 60 breast carcinoma 60 carboplatin paclitaxel 60 postoperatively 60 plus prednisone 60 Postoperative 60 g dL 60 atopic 60 mg BID 60 daunorubicin

Back to home page